Epithelial-mesenchymal interactions in biliary diseases

Seminars in Liver Disease

Volumn 31, Issue 1, 2011, Pages 11-32

  Fabris, Luca ^a,b   Strazzabosco, Mario ^b,c,d  

^a UNIVERSITY OF PADOVA   (Italy)

^b CeLiveR   (Italy)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

cholangiocytes; Cholangiopathies; ductular reaction; endothelial cells; myofibroblasts

Indexed keywords

ALPHA INTERFERON; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; FRACTALKINE; GELATINASE B; GROWTH FACTOR; INTERLEUKIN 6; MACROPHAGE ELASTASE; MORPHOGEN; NITRIC OXIDE; NOTCH RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SONIC HEDGEHOG PROTEIN; STROMAL CELL DERIVED FACTOR 1; TOLL LIKE RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN;

ARTICLE; BILE DUCT DISEASE; BILIARY TRACT DISEASE; CELL INFILTRATION; ENDOTHELIUM CELL; EPITHELIUM; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; LIVER FIBROSIS; LYMPHOCYTE; MACROPHAGE; MESENCHYME; MESENCHYME CELL; MOLECULAR BIOLOGY; MONOCYTE; MYOFIBROBLAST; PATHOGENESIS; PERICYTE; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STELLATE CELL;

ANIMALS; BILIARY TRACT; BILIARY TRACT DISEASES; CELL COMMUNICATION; CELL DIFFERENTIATION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MESODERM; SIGNAL TRANSDUCTION;

EID: 79951900204     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0031-1272832     Document Type: Article

References (201)

1. Lazaridis K N., Strazzabosco M, Larusso N F. The cholangiopathies: disorders of bili (Pubitemid 39457780)
2. Strazzabosco M, Fabris L, Spirli C. Pathophysiology of cholangiopathies. J Clin Gastroenterol 2005 39 4, Suppl 2 S90-S102 (Pubitemid 40397022)
3. Spirl C, Fabris L, Duner E et al. Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes. Gastroenterology 2003 124 3 737-753 (Pubitemid 36268491)
4. Liu Z, Sakamoto T, Ezure T et al. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium. Hepatology 1998 28 5 1260-1268 (Pubitemid 28493836)
5. Terada R, Yamamoto K, Hakoda T et al. Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: implications for inflammatory liver diseases. Lab Invest 2003 83 5 665-672 (Pubitemid 36618045)
6. Yokoyama T, Komori A, Nakamura M et al. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int 2006 26 4 467-476
7. Reynoso-Paz S, Coppel R L., Mackay I R., Bass N M., Ansari A A., Gershwin M E. The immunobiology of bile and biliary epithelium. Hepatology 1999 30 2 351-357 (Pubitemid 29357497)
8. Desmet V J. Histopathology of chronic cholestasis and adult ductopenic syndrome. Clin Liver Dis 1998 2 2 249-264, viii
9. Gaudio E, Barbaro B, Alvaro D et al. Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. Gastroenterology 2006 130 4 1270-1282
10. Fabris L, Cadamuro M, Fiorotto R et al. Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases. Hepatology 2006 43 5 1001-1012 (Pubitemid 43724625)
11. Caligiuri A, Glaser S, Rodgers R E. et al. Endothelin-1 inhibits secretin-stimulated ductal secretion by interacting with ETA receptors on large cholangiocytes. Am J Physiol 1998 275 4 Pt 1 G835-G846
12. Grappone C, Pinzani M, Parola M et al. Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats. J Hepatol 1999 31 1 100-109 (Pubitemid 29287615)
13. George J, Roulot D, Koteliansky V E., Bissell D M. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. Proc Natl Acad Sci U S A 1999 96 22 12719-12724 (Pubitemid 29513569)
14. Sedlaczek N, Jia J D., Bauer M et al. Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. Am J Pathol 2001 158 4 1239-1244 (Pubitemid 32281287)
15. Yasoshima M, Kono N, Sugawara H, Katayanagi K, Harada K, Nakanuma Y. Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study. Lab Invest 1998 78 1 89-100 (Pubitemid 28074312)
16. Nichols M T., Gidey E, Matzakos T et al. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid. Hepatology 2004 40 4 836-846 (Pubitemid 39288116)
17. Barnes B H., Tucker R M., Wehrmann F, Mack D G., Ueno Y, Mack C L. Cholangiocytes as immune modulators in rotavirus-induced murine biliary atresia. Liver Int 2009 29 8 1253-1261
18. Marra F, DeFranco R, Grappone C et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol 1998 152 2 423-430 (Pubitemid 28106388)
19. Saito J M., Maher J J. Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant. Gastroenterology 2000 118 6 1157-1168 (Pubitemid 30346993)
20. Fabris L, Strazzabosco M, Crosby H A. et al. Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations. Am J Pathol 2000 156 5 1599-1612 (Pubitemid 30646699)
21. Popov Y, Patsenker E, Stickel F et al. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. J Hepatol 2008 48 3 453-464
22. Patsenker E, Popov Y, Stickel F, Jonczyk A, Goodman S L., Schuppan D. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. Gastroenterology 2008 135 2 660-670
23. Desmet V J. The amazing universe of hepatic microstructure. Hepatology 2009 50 2 333-344
24. Omenetti A, Yang L, Li Y X. et al. Hedgehog-mediated mesenchymal- epithelial interactions modulate hepatic response to bile duct ligation. Lab Invest 2007 87 5 499-514 (Pubitemid 46633127)
25. Ader T, Norel R, Levoci L, Rogler L E. Transcriptional profiling implicates TGFbeta/BMP and Notch signaling pathways in ductular differentiation of fetal murine hepatoblasts. Mech Dev 2006 123 2 177-194 (Pubitemid 43227944)
26. Thompson M D., Monga S P. WNT/beta-catenin signaling in liver health and disease. Hepatology 2007 45 5 1298-1305 (Pubitemid 46775794)
27. Michalopoulos G K., Bowen W C., Mul K, Lopez-Talavera J C., Mars W. Hepatocytes undergo phenotypic transformation to biliary epithelium in organoid cultures. Hepatology 2002 36 2 278-283 (Pubitemid 34810346)
28. Apte U, Thompson M D., Cui S, Liu B, Cieply B, Monga S P. Wnt/beta-catenin signaling mediates oval cell response in rodents. Hepatology 2008 47 1 288-295 (Pubitemid 351171066)
29. Santoni-Rugiu E, Jelnes P, Thorgeirsson S S., Bisgaard H C. Progenitor cells in liver regeneration: molecular responses controlling their activation and expansion. APMIS 2005 113 11-12 876-902 (Pubitemid 43934227)
30. Li Z, White P, Tuteja G, Rubins N, Sackett S, Kaestner K H. Foxa1 and Foxa2 regulate bile duct development in mice. J Clin Invest 2009 119 6 1537-1545
31. Strazzabosco M. Foxa1 and Foxa2 regulate bile duct development in mice. J Hepatol 2010 52 5 765-767
32. Semela D, Das A, Langer D, Kang N, Leof E, Shah V. Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function. Gastroenterology 2008 135 2 671-679
33. Fernndez M, Semela D, Bruix J, Colle I, Pinzani M, Bosch J. Angiogenesis in liver disease. J Hepatol 2009 50 3 604-620
34. Medina J, Sanz-Cameno P, Garca-Buey L, Martn-Vlchez S, Lpez-Cabrera M, Moreno-Otero R. Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study. J Hepatol 2005 42 1 124-131 (Pubitemid 40038910)
35. Kawahara N, Ono M, Taguchi K et al. Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma. Hepatology 1998 28 6 1512-1517 (Pubitemid 28549120)
36. Abrahm S, Szab A, Kaszaki J et al. Kupffer cell blockade improves the endotoxin-induced microcirculatory inflammatory response in obstructive jaundice. Shock 2008 30 1 69-74
37. Shipley J M., Wesselschmidt R L., Kobayashi D K., Ley T J., Shapiro S D. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci U S A 1996 93 9 3942-3946 (Pubitemid 26144227)
38. Fallowfield J A., Mizuno M, Kendall T J. et al. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol 2007 178 8 5288-5295 (Pubitemid 46595314)
39. Popov Y, Sverdlov D Y., Bhaskar K R. et al. Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis. Am J Physiol Gastrointest Liver Physiol 2010 298 3 G323-G334
40. Wuestefeld T, Klein C, Streetz K L. et al. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 2003 278 13 11281-11288 (Pubitemid 36792685)
41. Jakubowski A, Ambrose C, Parr M et al. TWEAK induces liver progenitor cell proliferation. J Clin Invest 2005 115 9 2330-2340 (Pubitemid 41266195)
42. Shimoda S, Harada K, Niiro H et al. Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. Hepatology 2008 47 3 958-965 (Pubitemid 351449687)
43. Shimoda S, Harada K, Niiro H et al. CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis. Hepatology 2010 51 2 567-575
44. Klein I, Cornejo J C., Polakos N K. et al. Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood 2007 110 12 4077-4085 (Pubitemid 350248465)
45. Imamura M, Ogawa T, Sasaguri Y, Chayama K, Ueno H. Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats. Gastroenterology 2005 128 1 138-146 (Pubitemid 40039965)
46. Tacke F, Alvarez D, Kaplan T J. et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007 117 1 185-194 (Pubitemid 46048465)
47. Karlmark K R., Weiskirchen R, Zimmermann H W. et al. Hepatic recruitment of the inflammatory Gr1 + monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 2009 50 1 261-274
48. Zimmermann H W., Seidler S, Nattermann J et al. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS ONE 2010 5 6 e11049
49. Kinnman N, Hultcrantz R, Barbu V et al. PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury. Lab Invest 2000 80 5 697-707 (Pubitemid 30340654)
50. Schaffner F, Barka T, Popper H. Hepatic mesenchymal cell reaction in liver disease. Exp Mol Pathol 1963 31 419-441
51. Dranoff J A., Wells R G. Portal fibroblasts: Underappreciated mediators of biliary fibrosis. Hepatology 2010 51 4 1438-1444
52. Milani S, Herbst H, Schuppan D, Stein H, Surrenti C. Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol 1991 139 6 1221-1229
53. Kruglov E A., Nathanson R A., Nguyen T, Dranoff J A. Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts. Am J Physiol Gastrointest Liver Physiol 2006 290 4 G765-G771
54. Jhandier M N., Kruglov E A., Lavoie E G., Svigny J, Dranoff J A. Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2. J Biol Chem 2005 280 24 22986-22992 (Pubitemid 40853208)
55. Kinnman N, Francoz C, Barbu V et al. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest 2003 83 2 163-173 (Pubitemid 36255362)
56. Russo F P., Alison M R., Bigger B W. et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 2006 130 6 1807-1821 (Pubitemid 43668827)
57. Wells R G. The epithelial-to-mesenchymal transition in liver fibrosis: here today, gone tomorrow? Hepatology 2010 51 3 737-740
58. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002 36 2 200-209 (Pubitemid 34146426)
59. Friedman S L. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008 134 6 1655-1669 (Pubitemid 351615417)
60. Vias O, Bataller R, Sancho-Bru P et al. Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology 2003 38 4 919-929 (Pubitemid 37221675)
61. Winau F, Hegasy G, Weiskirchen R et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007 26 1 117-129 (Pubitemid 46109346)
62. Ankoma-Sey V, Wang Y, Dai Z. Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells. Hepatology 2000 31 1 141-148 (Pubitemid 30033700)
63. Novo E, Cannito S, Zamara E et al. Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. Am J Pathol 2007 170 6 1942-1953 (Pubitemid 47339268)
64. Novo E, di Bonzo L V., Cannito S, Colombatto S, Parola M. Hepatic myofibroblasts: a heterogeneous population of multifunctional cells in liver fibrogenesis. Int J Biochem Cell Biol 2009 41 11 2089-2093
65. Pinzani M, Marra F. Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis 2001 21 3 397-416 (Pubitemid 32923768)
66. Yavrom S, Chen L, Xiong S, Wang J, Rippe R A., Tsukamoto H. Peroxisome proliferator-activated receptor gamma suppresses proximal alpha1(I) collagen promoter via inhibition of p300-facilitated NF-I binding to DNA in hepatic stellate cells. J Biol Chem 2005 280 49 40650-40659 (Pubitemid 41780556)
67. Hong F, Tuyama A, Lee T F. et al. Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation. Hepatology 2009 49 6 2055-2067
68. Chesney J, Metz C, Stavitsky A B., Bacher M, Bucala R. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 1998 160 1 419-425 (Pubitemid 28116757)
69. Quan T E., Cowper S, Wu S P., Bockenstedt L K., Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004 36 4 598-606 (Pubitemid 38316817)
70. Keeley E C., Mehrad B, Strieter R M. The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders. Thromb Haemost 2009 101 4 613-618
71. Asawa S, Saito T, Satoh A et al. Participation of bone marrow cells in biliary fibrosis after bile duct ligation. J Gastroenterol Hepatol 2007 22 11 2001-2008 (Pubitemid 47525070)
72. Phillips R J., Burdick M D., Hong K et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004 114 3 438-446 (Pubitemid 39071616)
73. Strieter R M., Gomperts B N., Keane M P. The role of CXC chemokines in pulmonary fibrosis. J Clin Invest 2007 117 3 549-556 (Pubitemid 46348509)
74. Mehrad B, Burdick M D., Zisman D A., Keane M P., Belperio J A., Strieter R M. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 2007 353 1 104-108 (Pubitemid 44958347)
75. Andersson-Sjland A, de Alba C G., Nihlberg K et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 2008 40 10 2129-2140
76. Kisseleva T, Uchinami H, Feirt N et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 2006 45 3 429-438 (Pubitemid 44142115)
77. Guo J, Friedman S L. Hepatic fibrogenesis. Semin Liver Dis 2007 27 4 413-426 (Pubitemid 350071841)
78. Jafri M, Donnelly B, Allen S et al. Cholangiocyte expression of alpha2beta1-integrin confers susceptibility to rotavirus-induced experimental biliary atresia. Am J Physiol Gastrointest Liver Physiol 2008 295 1 G16-G26
79. Wang B, Dolinski B M., Kikuchi N et al. Role of alphavbeta6 integrin in acute biliary fibrosis. Hepatology 2007 46 5 1404-1412 (Pubitemid 350155522)
80. Margadant C, Sonnenberg A. Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep 2010 11 2 97-105
81. Maeda N, Kawada N, Seki S et al. Stimulation of proliferation of rat hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways. J Biol Chem 2003 278 21 18938-18944 (Pubitemid 36799277)
82. Henderson N C., Mackinnon A C., Farnworth S L. et al. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci U S A 2006 103 13 5060-5065
83. Chiquet-Ehrismann R, Mackie E J., Pearson C A., Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986 47 1 131-139 (Pubitemid 17181535)
84. Swindle C S., Tran K T., Johnson T D. et al. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J Cell Biol 2001 154 2 459-468 (Pubitemid 34288473)
85. Van Eyken P, Sciot R, Desmet V J. Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. An immunohistochemical study. J Hepatol 1990 11 1 43-52 (Pubitemid 20250826)
86. Van Eyken P, Geerts A, De Bleser P et al. Localization and cellular source of the extracellular matrix protein tenascin in normal and fibrotic rat liver. Hepatology 1992 15 5 909-916
87. Miyazaki H, Van Eyken P, Roskams T, De Vos R, Desmet V J. Transient expression of tenascin in experimentally induced cholestatic fibrosis in rat liver: an immunohistochemical study. J Hepatol 1993 19 3 353-366 (Pubitemid 24029911)
88. Aishima S, Taguchi K, Terashi T, Matsuura S, Shimada M, Tsuneyoshi M. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma. Mod Pathol 2003 16 10 1019-1027 (Pubitemid 37280818)
89. Roskams T, Rosenbaum J, De Vos R, David G, Desmet V. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases. Hepatology 1996 24 3 524-532 (Pubitemid 26295991)
90. Liu B, Paranjpe S, Bowen W C. et al. Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation. Am J Pathol 2009 175 2 717-724
91. Karlsen T H., Franke A, Melum E et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 2010 138 3 1102-1111
92. Yasoshima M, Tsuneyama K, Harada K, Sasaki M, Gershwin M E., Nakanuma Y. Immunohistochemical analysis of cell-matrix adhesion molecules and their ligands in the portal tracts of primary biliary cirrhosis. J Pathol 2000 190 1 93-99 (Pubitemid 30053359)
93. Yasoshima M, Sato Y, Furubo S et al. Matrix proteins of basement membrane of intrahepatic bile ducts are degraded in congenital hepatic fibrosis and Caroli's disease. J Pathol 2009 217 3 442-451
94. Joplin R, Hishida T, Tsubouchi H et al. Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor. J Clin Invest 1992 90 4 1284-1289
95. Ishida Y, Smith S, Wallace L et al. Ductular morphogenesis and functional polarization of normal human biliary epithelial cells in three-dimensional culture. J Hepatol 2001 35 1 2-9 (Pubitemid 32646218)
96. Matsuda Y, Matsumoto K, Ichida T, Nakamura T. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem 1995 118 3 643-649
97. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 1996 24 3 636-642 (Pubitemid 26296009)
98. Inagaki Y, Higashi K, Kushida M et al. Hepatocyte growth factor suppresses profibrogenic signal transduction via nuclear export of Smad3 with galectin-7. Gastroenterology 2008 134 4 1180-1190 (Pubitemid 351451969)
99. Xia J L., Dai C, Michalopoulos G K., Liu Y. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol 2006 168 5 1500-1512
100. Pinzani M, Gesualdo L, Sabbah G M., Abboud H E. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989 84 6 1786-1793 (Pubitemid 20016182)
101. Friedman S L., Arthur M J. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J Clin Invest 1989 84 6 1780-1785 (Pubitemid 20016181)
102. Kinnman N, Goria O, Wendum D et al. Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury. Lab Invest 2001 81 12 1709-1716 (Pubitemid 33144433)
103. Lechuga C G., Hernndez-Nazara Z H., Hernndez E et al. PI3K is involved in PDGF-beta receptor upregulation post-PDGF-BB treatment in mouse HSC. Am J Physiol Gastrointest Liver Physiol 2006 291 6 G1051-G1061 (Pubitemid 44904159)
104. Rovida E, Navari N, Caligiuri A, Dello Sbarba P, Marra F. ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. J Hepatol 2008 48 1 107-115 (Pubitemid 350191987)
105. Melton A C., Yee H F. Hepatic stellate cell protrusions couple platelet-derived growth factor-BB to chemotaxis. Hepatology 2007 45 6 1446-1453 (Pubitemid 46918328)
106. Borkham-Kamphorst E, van Roeyen C R., Ostendorf T, Floege J, Gressner A M., Weiskirchen R. Pro-fibrogenic potential of PDGF-D in liver fibrosis. J Hepatol 2007 46 6 1064-1074 (Pubitemid 46669736)
107. Liu C, Gaa M D., Swenson E S., Vellucci V F., Reiss M, Wells R G. Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. J Biol Chem 2003 278 13 11721-11728 (Pubitemid 36792736)
108. Massagu J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005 19 23 2783-2810 (Pubitemid 41739965)
109. Inagaki Y, Okazaki I. Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 2007 56 2 284-292
110. Roy H, Bhardwaj S, Yl-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 2006 580 12 2879-2887 (Pubitemid 43729175)
111. Morisada T, Kubota Y, Urano T, Suda T, Oike Y. Angiopoietins and angiopoietin-like proteins in angiogenesis. Endothelium 2006 13 2 71-79 (Pubitemid 44173109)
112. Gaudio E, Franchitto A, Pannarale L et al. Cholangiocytes and blood supply. World J Gastroenterol 2006 12 22 3546-3552 (Pubitemid 43997031)
113. Fabris L, Cadamuro M, Libbrecht L et al. Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development. Hepatology 2008 47 2 719-728 (Pubitemid 351280740)
114. Spirli C, Okolicsanyi S, Fiorotto R et al. ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice. Gastroenterology 2010 138 1 360-371, e7
115. Spirli C, Okolicsanyi S, Fiorotto R et al. Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice. Hepatology 2010 51 5 1778-1788
116. Igarashi P, Somlo S. Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol 2002 13 9 2384-2398 (Pubitemid 34925250)
117. Wilson P D. Polycystic kidney disease: new understanding in the pathogenesis. Int J Biochem Cell Biol 2004 36 10 1868-1873 (Pubitemid 38760015)
118. Yoshiji H, Kuriyama S, Yoshii J et al. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut 2003 52 9 1347-1354 (Pubitemid 37026470)
119. Brodsky K S., McWilliams R R., Amura C R., Barry N P., Doctor R B. Liver cyst cytokines promote endothelial cell proliferation and development. Exp Biol Med (Maywood) 2009 234 10 1155-1165
120. Aiuti A, Webb I J., Bleul C, Springer T, Gutierrez-Ramos J C. The chemokine SDF-1 is a chemoattractant for human CD34 + hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34 + progenitors to peripheral blood. J Exp Med 1997 185 1 111-120 (Pubitemid 27039446)
121. Bleul C C., Schultze J L., Springer T A. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J Exp Med 1998 187 5 753-762 (Pubitemid 28115191)
122. Tachibana K, Hirota S, Iizasa H et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998 393 6685 591-594 (Pubitemid 28319250)
123. Coulomb-L'Hermin A, Amara A, Schiff C et al. Stromal cell-derived factor 1 (SDF-1) and antenatal human B cell lymphopoiesis: expression of SDF-1 by mesothelial cells and biliary ductal plate epithelial cells. Proc Natl Acad Sci U S A 1999 96 15 8585-8590 (Pubitemid 29354835)
124. Kollet O, Shivtiel S, Chen Y Q. et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34 + stem cell recruitment to the liver. J Clin Invest 2003 112 2 160-169 (Pubitemid 38056352)
125. Ohira S, Itatsu K, Sasaki M et al. Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma. Pathol Int 2006 56 7 381-389 (Pubitemid 43886802)
126. Ohira S, Sasaki M, Harada K et al. Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma. Am J Pathol 2006 168 4 1155-1168
127. Bradham D M., Igarashi A, Potter R L., Grotendorst G R. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991 114 6 1285-1294 (Pubitemid 21909886)
128. O'Brien T P., Yang G P., Sanders L, Lau L F. Expression of cyr61, a growth factor-inducible immediate-early gene. Mol Cell Biol 1990 10 7 3569-3577 (Pubitemid 20198182)
129. Ryseck R P., Macdonald-Bravo H, Matti M G., Bravo R. Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. Cell Growth Differ 1991 2 5 225-233
130. Igarashi A, Okochi H, Bradham D M., Grotendorst G R. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993 4 6 637-645 (Pubitemid 23183611)
131. Paradis V, Dargere D, Bonvoust F, Vidaud M, Segarini P, Bedossa P. Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab Invest 2002 82 6 767-774
132. Gao R, Ball D K., Perbal B, Brigstock D R. Connective tissue growth factor induces c-fos gene activation and cell proliferation through p44/42 MAP kinase in primary rat hepatic stellate cells. J Hepatol 2004 40 3 431-438 (Pubitemid 38230844)
133. Paradis V, Dargere D, Vidaud M et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 1999 30 4 968-976 (Pubitemid 29458286)
134. Kobayashi H, Hayashi N, Hayashi K, Yamataka A, Lane G J., Miyano T. Connective tissue growth factor and progressive fibrosis in biliary atresia. Pediatr Surg Int 2005 21 1 12-16 (Pubitemid 40169451)
135. Gardini A, Corti B, Fiorentino M et al. Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma. Dig Liver Dis 2005 37 4 269-274 (Pubitemid 41070525)
136. Yang L, Wang Y, Mao H et al. Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells. J Hepatol 2008 48 1 98-106 (Pubitemid 350191986)
137. Omenetti A, Diehl A M. The adventures of sonic hedgehog in development and repair. II. Sonic hedgehog and liver development, inflammation, and cancer. Am J Physiol Gastrointest Liver Physiol 2008 294 3 G595-G598 (Pubitemid 351468754)
138. Omenetti A, Porrello A, Jung Y et al. Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest 2008 118 10 3331-3342
139. Jung Y, McCall S J., Li Y X., Diehl A M. Bile ductules and stromal cells express hedgehog ligands and/or hedgehog target genes in primary biliary cirrhosis. Hepatology 2007 45 5 1091-1096 (Pubitemid 46775770)
140. Omenetti A, Popov Y, Jung Y et al. The hedgehog pathway regulates remodelling responses to biliary obstruction in rats. Gut 2008 57 9 1275-1282
141. Logan C Y., Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004 20 781-810 (Pubitemid 39488658)
142. Sackett S D., Gao Y, Shin S et al. Foxl1 promotes liver repair following cholestatic injury in mice. Lab Invest 2009 89 12 1387-1396
143. Monga S P., Monga H K., Tan X, Mul K, Pediaditakis P, Michalopoulos G K. Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. Gastroenterology 2003 124 1 202-216 (Pubitemid 36055352)
144. Hussain S Z., Sneddon T, Tan X, Micsenyi A, Michalopoulos G K., Monga S P. Wnt impacts growth and differentiation in ex vivo liver development. Exp Cell Res 2004 292 1 157-169 (Pubitemid 38058272)
145. Decaens T, Godard C, de Reynis A et al. Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate. Hepatology 2008 47 1 247-258 (Pubitemid 351171062)
146. Jiang F, Parsons C J., Stefanovic B. Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. J Hepatol 2006 45 3 401-409 (Pubitemid 44142112)
147. Myung S J., Yoon J H., Gwak G Y. et al. Wnt signaling enhances the activation and survival of human hepatic stellate cells. FEBS Lett 2007 581 16 2954-2958 (Pubitemid 46899038)
148. Cheng J H., She H, Han Y P. et al. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2008 294 1 G39-G49
149. Montcouquiol M, Crenshaw E B. III, Kelley M W. Noncanonical Wnt signaling and neural polarity. Annu Rev Neurosci 2006 29 363-386 (Pubitemid 44476850)
150. Lancaster M A., Gleeson J G. Cystic kidney disease: the role of Wnt signaling. Trends Mol Med 2010 16 8 349-360
151. Lai E C. Notch signaling: control of cell communication and cell fate. Development 2004 131 5 965-973 (Pubitemid 38380451)
152. Cornell R A., Eisen J S. Notch in the pathway: the roles of Notch signaling in neural crest development. Semin Cell Dev Biol 2005 16 6 663-672 (Pubitemid 41506974)
153. Blank U, Karlsson G, Karlsson S. Signaling pathways governing stem-cell fate. Blood 2008 111 2 492-503
154. Chiba S. Notch signaling in stem cell system. Stem Cells 2006 24 2437-2447 (Pubitemid 44674304)
155. Gridley T. Notch signaling and inherited disease syndromes. Hum Mol Genet 2003 12 Spec No 1 R9-R13 (Pubitemid 36442950)
156. Schweisguth F. Regulation of notch signaling activity. Curr Biol 2004 14 3 R129-R138 (Pubitemid 38215343)
157. Zong Y, Panikkar A, Xu J et al. Notch signaling controls liver development by regulating biliary differentiation. Development 2009 136 10 1727-1739
158. Lemaigre F P. Notch signaling in bile duct development: new insights raise new questions. Hepatology 2008 48 2 358-360
159. Tanimizu N, Miyajima A. Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors. J Cell Sci 2004 117 Pt 15 3165-3174 (Pubitemid 39139903)
160. McDaniell R, Warthen D M., Sanchez-Lara P A. et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 2006 79 1 169-173 (Pubitemid 43927389)
161. Li L, Krantz I D., Deng Y et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 1997 16 3 243-251
162. Oda T, Elkahloun A G., Pike B L. et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 1997 16 3 235-242
163. Crosnier C, Atti-Bitach T, Encha-Razavi F et al. JAGGED1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome. Hepatology 2000 32 3 574-581
164. Piccoli D A., Spinner N B. Alagille syndrome and the Jagged1 gene. Semin Liver Dis 2001 21 4 525-534 (Pubitemid 33131044)
165. Desmet V J. Ludwig symposium on biliary disorderspart I. Pathogenesis of ductal plate abnormalities. Mayo Clin Proc 1998 73 1 80-89
166. Katuri V, Tang Y, Li C et al. Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression. Oncogene 2006 25 13 1871-1886
167. Brabletz S, Schmalhofer O, Brabletz T. Gastrointestinal stem cells in development and cancer. J Pathol 2009 217 2 307-317
168. Fujikura J, Hosoda K, Iwakura H et al. Notch/Rbp-j signaling prevents premature endocrine and ductal cell differentiation in the pancreas. Cell Metab 2006 3 1 59-65
169. Farnie G, Clarke R B. Mammary stem cells and breast cancerrole of Notch signalling. Stem Cell Rev 2007 3 2 169-175 (Pubitemid 350129719)
170. Blank U, Karlsson G, Karlsson S. Signaling pathways governing stem-cell fate. Blood 2008 111 2 492-503
171. Alexson T O., Hitoshi S, Coles B L., Bernstein A, van der Kooy D. Notch signaling is required to maintain all neural stem cell populationsirrespective of spatial or temporal niche. Dev Neurosci 2006 28 1-2 34-48
172. Zanotti S, Canalis E. Notch and the skeleton. Mol Cell Biol 2010 30 4 886-896
173. Felszeghy S, Suomalainen M, Thesleff I. Notch signalling is required for the survival of epithelial stem cells in the continuously growing mouse incisor. Differentiation 2010 80 241-248
174. Dellatore S M., Garcia A S., Miller W M. Mimicking stem cell niches to increase stem cell expansion. Curr Opin Biotechnol 2008 19 5 534-540
175. Nijjar S S., Wallace L, Crosby H A., Hubscher S G., Strain A J. Altered Notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects. Am J Pathol 2002 160 5 1695-1703 (Pubitemid 34525649)
176. Spee B, Carpino G, Schotanus B A. et al. Characterisation of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signalling. Gut 2010 59 2 247-257
177. Fabris L, Cadamuro M, Guido M et al. Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling. Am J Pathol 2007 171 2 641-653 (Pubitemid 47344696)
178. Fiorotto R, Spirli C, Scirpo R et al. Progenitor cell activation and liver repair is altered in Notch2- and RBP-Jk-defective mice exposed to cholestatic injuries. J Hepatol 2010 52 S45
179. Sawitza I, Kordes C, Reister S, Hussinger D. The niche of stellate cells within rat liver. Hepatology 2009 50 5 1617-1624
180. Venkov C D., Link A J., Jennings J L. et al. A proximal activator of transcription in epithelial-mesenchymal transition. J Clin Invest 2007 117 2 482-491 (Pubitemid 46203977)
181. Rhyu D Y., Yang Y, Ha H et al. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 2005 16 3 667-675 (Pubitemid 41725103)
182. Zeisberg M, Neilson E G. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009 119 6 1429-1437
183. Sato Y, Harada K, Ozaki S et al. Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat. Am J Pathol 2007 171 6 1859-1871
184. Harada K, Sato Y, Ikeda H et al. Epithelial-mesenchymal transition induced by biliary innate immunity contributes to the sclerosing cholangiopathy of biliary atresia. J Pathol 2009 217 5 654-664
185. Sato Y, Harada K, Itatsu K et al. Epithelial-mesenchymal transition induced by transforming growth factor-beta1/snail activation aggravates invasive growth of cholangiocarcinoma. Am J Pathol 2010 177 1 141-152
186. Strutz F, Okada H, Lo C W. et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995 130 2 393-405
187. Le Hir M, Hegyi I, Cueni-Loffing D, Loffing J, Kaissling B. Characterization of renal interstitial fibroblast-specific protein 1/S100A4-positive cells in healthy and inflamed rodent kidneys. Histochem Cell Biol 2005 123 4-5 335-346 (Pubitemid 40922217)
188. Taura K, Miura K, Iwaisako K et al. Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 2010 51 3 1027-1036
189. Lorent K, Yeo S Y., Oda T et al. Inhibition of Jagged-mediated Notch signaling disrupts zebrafish biliary development and generates multi-organ defects compatible with an Alagille syndrome phenocopy. Development 2004 131 22 5753-5766 (Pubitemid 39625217)
190. Antoniou A, Raynaud P, Cordi S et al. Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9. Gastroenterology 2009 136 7 2325-2333
191. Libbrecht L, Spinner N B., Moore E C., Cassiman D, Van Damme-Lombaerts R, Roskams T. Peripheral bile duct paucity and cholestasis in the liver of a patient with Alagille syndrome: further evidence supporting a lack of postnatal bile duct branching and elongation. Am J Surg Pathol 2005 29 6 820-826 (Pubitemid 40734433)
192. Clotman F, Jacquemin P, Plumb-Rudewiez N et al. Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors. Genes Dev 2005 19 16 1849-1854 (Pubitemid 41186985)
193. Blechacz B, Gores G J. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008 48 1 308-321 (Pubitemid 351975555)
194. Mueller M M., Fusenig N E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004 4 11 839-849 (Pubitemid 39472951)
195. Kalluri R, Weinberg R A. The basics of epithelial-mesenchymal transition. J Clin Invest 2009 119 6 1420-1428
196. Yauch R L., Gould S E., Scales S J. et al. A paracrine requirement for hedgehog signalling in cancer. Nature 2008 455 7211 406-410
197. Erez N, Truitt M, Olson P, Arron S T., Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010 17 2 135-147
198. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006 6 5 392-401
199. Santamaria-Martnez A, Barquinero J, Barbosa-Desongles A et al. Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis. Exp Cell Res 2009 315 17 3004-3013
200. Thiery J P., Sleeman J P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006 7 2 131-142 (Pubitemid 43278296)
201. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 2009 119 6 1417-1419